Smartlink Partners Fund Invests 2.8 Million PLN in American Startup WearLinq, Offering a Minimalist Heart Monitoring Device, eWave
The Smartlink Partners fund has invested 2.8 million PLN in the American startup, WearLinq, which offers a minimalistic eWave device for heart monitoring using the Holter method. The device, paired with an app, offers real-time access to EKG measurement data 24/7.
The Smartlink Partners fund was established in 2023 by JRH ASI S.A. (formerly JR Holding) in partnership with the Corporate Connections Entrepreneur Association, and experienced managers Bartek Kurylak and Paweł Szydłowski, who currently oversee the fund. It is a fully private fund, with large, Polish private entrepreneurs as investors.
The eWave device, of small size (approximately the size of a matchbox), is attached by a flexible “patch” that’s adhered to a patient’s chest. Besides providing a 6-channel measurement of parameters, it delivers a detailed, high-quality, multidimensional image of the heart’s activity with exceptional visibility of a 24/7 EKG recording. The eWave, focusing on mobile heart telemetry and extended Holter monitoring, provides unbeatable convenience along with superior diagnostic value compared to the competition, thanks to wireless communication. The dedicated eWave app makes it easier for both patients and doctors to access real-time data. A single charge guarantees five days of operation.
“WearLinq has a license agreement with Stanford University, from where the company’s founders originate, where I met them. The product is FDA certified and offers the possibility of reimbursement for medical tests (such as Holter and telemetric monitoring in real-time), enabling financing through health insurance in the vast US market. Rapid sales growth testifies to the market fit of the product, and the forecast for growth and replacement of large competitors are promising,” says Bartek Kurylak, Partner at Smartlink Partners.
The company collaborates with cardiologists who run private medical practices, as well as other clinical facilities in the US. WearLinq plans to apply for additional FDA certifications, including those relevant to the application of artificial intelligence algorithms for disease diagnostics.
“We are happy to cooperate with a fund from Poland, not just because I am Polish, but also because we have an engineering team in Poland, which helps us develop algorithms that support our products,” says Konrad Morzkowski, CEO & Co-Founder of Wearlinq.
To date, the Smartlink Fund has finalized six investments and is in the process of investing in four other projects in various CEE countries. Smartlink invests in companies covering SaaS (HRtech, AI), Medtech, and Deeptech (Spacetech), and these companies already have market-tested products with growing revenue, which are typical of seed to Series A rounds. Besides providing financing, the fund is eager to connect its portfolio companies with their network of business owners for possible opportunities, and the fund’s partners actively engage in collaboration with portfolio companies for future investment rounds.
Source: https://managerplus.pl/smartlink-partners-inwestuje-w-medtech-wearlinq-83091
